Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSV-2”

85 trials

Showing 20 of 85 results

Testing effectiveness (Phase 2)Study completedNCT04165122
What this trial is testing

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Who this might be right for
Herpes Genitalis
Heidelberg ImmunoTherapeutics GmbH 122
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Testing effectiveness (Phase 2)Study completedNCT02515175
What this trial is testing

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 131
Post-approval studies (Phase 4)Study completedNCT00116844
What this trial is testing

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Who this might be right for
Infections, Herpesviridae
GlaxoSmithKline 73
Early research (Phase 1)UnknownNCT01037621
What this trial is testing

Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C

Who this might be right for
Hepatitis C Virus InfectionInfectionHerpesvirus 2, Human
G.V. (Sonny) Montgomery VA Medical Center 50
Post-approval studies (Phase 4)Ended earlyNCT00495716
What this trial is testing

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

Who this might be right for
Genital Herpes
University of Washington 72
Large-scale testing (Phase 3)Study completedNCT00194519
What this trial is testing

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Who this might be right for
HIV InfectionHerpes Simplex, GenitalSexually Transmitted Diseases
University of Washington 3,408
Large-scale testing (Phase 3)Study completedNCT00332878
What this trial is testing

Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African Communities

Who this might be right for
HIV Infections
Medical Research Council, South Africa 2,801
Large-scale testing (Phase 3)Study completedNCT00378976
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

Who this might be right for
HIV InfectionHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Early research (Phase 1)Study completedNCT00310271
What this trial is testing

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

Who this might be right for
HSV-2
PowderMed 42
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Early research (Phase 1)Ended earlyNCT04762511
What this trial is testing

A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years

Who this might be right for
Herpes Simplex
GlaxoSmithKline 17
Not applicableWithdrawnNCT04294030
What this trial is testing

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
HSV-2 InfectionHerpes Simplex Virus Infection
NOWDiagnostics, Inc.
Post-approval studies (Phase 4)Study completedNCT02432404
What this trial is testing

Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

Who this might be right for
Bacterial Vaginosis
University of Washington 81
Post-approval studies (Phase 4)Study completedNCT00306293
What this trial is testing

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Who this might be right for
Herpes Labialis
GlaxoSmithKline 70
Early research (Phase 1)Study completedNCT00274300
What this trial is testing

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

Who this might be right for
HSV-2
PowderMed 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04979975
What this trial is testing

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 200
Not applicableStudy completedNCT04205721
What this trial is testing

Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa

Who this might be right for
HSV-2 InfectionHIV InfectionsPregnancy Related
University of North Carolina, Chapel Hill 23,061
Not applicableUnknownNCT03597243
What this trial is testing

Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation

Who this might be right for
HIV/AIDSHSV-2 Infection
National Institute for Medical Research, Tanzania 3,120
Not applicableStudy completedNCT00495573
What this trial is testing

HSV-2 Shedding Resolution After Acyclovir Treatment

Who this might be right for
Genital Herpes
University of Washington 36
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation